Evolution of Hepatitis B Virus (HBV) Serologic Markers Among Antiretroviral-Naive Young People Living With Human Immunodeficiency Virus Who Had Undergone Neonatal HBV Vaccination and Initiated Antiretroviral Therapy
Journal
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Journal Volume
75
Journal Issue
5
Pages
882
Date Issued
2022-09-14
Author(s)
Huang, Sung Hsi
Chen, Guan Jhou
Su, Yi Ching
Su, Li Hsin
Liu, Wen Chun
Abstract
With initiation of antiretroviral therapy (ART) containing nucleos(t)ide reverse-transcriptase inhibitors (NRTIs) with anti-hepatitis B virus (HBV) activity, the evolution of HBV serologic markers among people living with human immunodeficiency virus (PLWH) who were born in the era of nationwide neonatal HBV vaccination is rarely investigated.
Subjects
chemoprophylaxis; horizontal transmission; immunization; sexual transmission; tenofovir; viral hepatitis
SDGs
Publisher
OXFORD UNIV PRESS INC
Type
journal article